Bioequivalence Study Between Two Oral Formulations of Ibuprofen 800 mg Tablets Under Fed Conditions

Bioequivalency Clinical Trial

Official title:
A Randomized, Single-Dose, Two-Way Crossover Relative Bioavailability Study of Ibuprofen Tablet Formulations in Normal, Healthy Men and Women Following Standard Meal

Status Completed

Clinical Trial Summary

Compare the rate and extent of absorption of two oral formulations of Ibuprofen 800 mg Tablets, administered as a 1 x 800 mg tablet, under fed conditions.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Bio-equivalence Study, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Bioequivalency

Clinical Trial Details

NCT number	NCT00803946
Study type	Interventional
Source	Perrigo Company
Contact
Status	Completed
Phase	Phase 1
Start date	November 2003

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT05665283` - A Single Dose BE Study of X-396 in Healthy Volunteers Under Fasted Conditions	Phase 1
Unknown status	`NCT01227811` - Single Dose Two-periods Crossover Bioequivalence Study of Darifenacin Tablets in Healthy Volunteers.	Phase 1
Completed	`NCT01039233` - Bioequivalence Study of Bicalutamide 50 mg Tablet and Casodex 50 mg Tablet in Healthy Subjects Under Fasting Conditions	Phase 1
Completed	`NCT00803764` - Bioequivalence Study Between Two Oral Formulations of Naproxen 500 mg Tablets Under Fed Conditions	Phase 1
Completed	`NCT00804401` - Bioequivalence Study Between Two Oral Formulations of Naproxen 500 mg Tablets Under Fasting Conditions	Phase 1
Completed	`NCT00804440` - Bioequivalence Study Between Two Oral Formulations of Ibuprofen 800 mg Tablets Under Fasting Conditions	Phase 1
Unknown status	`NCT01229280` - Single Dose Bioequivalence Study of Darifenacin Tablets 7.5 mg in Fed Healthy Volunteers.	Phase 1